NGNE
Neurogene
$30.42
+$3.43 (+12.71%)Oct 28, 2026
Key metrics
The numbers that frame NGNE today
- Market cap
- $608.75M
- ROIC
- -69.8%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $15.93
- 52wk High
- $43.66
Growth
Revenue and earnings trend for NGNE
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NGNE
Is Neurogene a good buy?
No. Neurogene has strong momentum, but poor quality undercuts the setup. Growth looks poor. That could put pressure on the long-term business case. We think Neurogene is selling at a very high price.
What is the market capitalization of NGNE?
Neurogene's market capitalization is $608.75M.
What is the 52-week high for NGNE stock?
The 52-week high for Neurogene is $43.66. The current close of $30.42 is 30.3% below that high.
What is the 52-week low for NGNE stock?
The 52-week low for Neurogene is $15.93. The current close of $30.42 is 91% above that low.
Does NGNE stock pay dividends?
Neurogene does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NGNE?
Neurogene's Debt / Equity ratio is 0.04.